Inovio Ebola vaccine shows positive results in phase I human trials
The vaccine was safe, tolerable, and generated strong T cell and antibody responses in its fully enrolled phase I study of 75 healthy subjects.
Mar 30, 2016, 21:49 PM IST
The vaccine was safe, tolerable, and generated strong T cell and antibody responses in its fully enrolled phase I study of 75 healthy subjects.
Mar 30, 2016, 21:49 PM IST